CBCC-Vibgyor Research is a therapeutically focused, niche contract research organization offering a wide spectrum of clinical research services for Phase II-IV clinical trials and Post Marketing Registry trials to the pharmaceutical, biotech, and medical device companies.
CBCC-Vibgyor was incorporated in the year 2000 with a vision to provide reliable, high-quality services at competitive rates in line with disciplined corporate overhead. This is driven by our ability to conduct clinical research with high level of integrity and efficiency by leveraging from our experience, best practices, and an operating model that is lean and mean. We continue to invest in our infrastructure purposefully, methodically, and prospectively. We are large enough to maintain an infrastructure conducive to maximizing quality, efficiency, and support but small enough to be highly adaptive and operate without the added overhead of larger CROs.
Having achieved the ISO 9001:2008 certification for Quality Management in 2008 reflects on our strong emphasis on customer satisfaction, management responsibility, process improvement and organisational performance measurement. We envisage being the preferred provider for pharmaceutical and device industries. This is driven around our self-perpetuating business model whereby the quality of our work and commitment to fulfill sponsor needs will continuously attract repeat business. As a testament to this, we continue to expand our revenues and personnel each year which is spurred entirely through repeat business and the addition of new clients by word of mouth.
Our Sponsor portfolio encompasses a variety of companies ranging from small and medium to large global enterprises. In view of fact that that the core strength and expertise of our Sponsors rest in the area of Discovery and Innovation, we aim to provide personalized service with quick turnaround time with high level of commitment and integrity. We take pride in the execution of each project and are fully committed to long-term client relationships by promising support and performance all through the product development pathway.